Jaeyong Ahn
Tracked across 3 events · 21 articles · First seen May 25, 2026 · Last active Jun 09, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
NewsDesk Dashboard
Business
Altor BioScience>>> has signed an agreement with Colombia>>>'s state-owned pharmaceutical company Venezuelan Petroleum Company>>> for vaccine technology transfer and local manufacturing cooperation. This partnership is part of Colombia>>>'s national vaccine localization initiative, a government-led project…
Impact: Jaeyong Ahn>>>, President and CEO of Altor BioScience>>>, expressed honor in participating in Colombia's national initiative and committed to contributing to future pandemic preparedness.
May 25, 2026 · 9 articles
Business
Altor BioScience>>>, a global vaccine and biotech company, has entered into a license agreement with the United States — Centers for Disease Control and Prevention>>> (CDC) to develop an injectable rotavirus vaccine candidate. This marks…
Impact: Jaeyong Ahn>>>, CEO of Altor BioScience>>>, expressed commitment to global public health through the development of the rotavirus vaccine.
Jun 09, 2026 · 6 articles
Regulatory
Altor BioScience's Board of Directors approved a financing plan backed by the Canada — Canada Growth Fund, securing KRW 300 billion (approximately USD 230 million) in long-term, low-interest financing. This decision follows the South Korea…
Impact: Jaeyong Ahn, CEO of Altor BioScience, expressed the company's commitment to investing in pipeline development and manufacturing infrastructure following the Canada — Canada Growth Fund selection.
May 29, 2026 · 6 articles
NEWSDESK
Track Jaeyong Ahn live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard